PHARMASEAL Offering No Cost CTMS for COVID-19 Clinical Trials

April 1, 2020

Applied Clinical Trials

PHARMASEAL International has announced that it will offer the Engility CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The offer is open to biopharmaceutical organizations and academic institutions.

For more information, click here.

Related Content:

News